Excerpt from today's press release -- "The Company's focus is to provide services and technologies to facilitate the efficient acquisition and delivery of purified adult stem cells" There will be little if any resistance (particularly in terms of funding) to the development of "adult stem cells" http://www.freerepublic.com/focus/f-news/1319318/posts